Post-kala-azar dermal leishmaniasis associated with AIDS

Post-kala-azar dermal leishmaniasis associated with AIDS

Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact that there are many reports about the association of visceral leishmaniasis and AIDS, PKDL is very uncommon in HIV-positive patients, and so far only four cases have been documented in the literature...

Full description

Bibliographic Details
Main Authors:	Achiléa Bittencourt, Nancy Silva, Andréa Straatmann, Victor Luiz Correia Nunes, Ivonise Follador, Roberto Badaró
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Visceral leishmaniasis post-kala-azar dermal leishmaniasis AIDS
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000600008&lng=en&tlng=en

Similar Items

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2003-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2002-01-01)

Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020-01-01)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)

A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery
by: Md. Mehedi Hasan, et al.
Published: (2023-12-01)

Post kala-azar dermal leishmaniasis: Clinical features and differential diagnosis
by: Piyush Kumar, et al.
Published: (2021-01-01)

Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
by: Abdul Mabood Khan, et al.
Published: (2014-03-01)

Visceral leishmaniasis: An immunological viewpoint on asymptomatic infections and post kala azar dermal leishmaniasis
by: Neeraj Tiwari, et al.
Published: (2018-01-01)

Visceral Leishmaniasis (Kala-Azar) Outbreak in Somali Refugees and Kenyan Shepherds, Kenya
by: Günter Boussery, et al.
Published: (2001-06-01)

Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states
by: Suman Saurabh, et al.
Published: (2020-01-01)

Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination
by: Awnish Kumar, et al.
Published: (2023-08-01)

Seroepidemiological Study of Visceral Leishmaniasis (Kala-azar) in Ardabil Province, Iran, 1986 – 2009
by: S Molaie, et al.
Published: (2010-10-01)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
by: Greta Volpedo, et al.
Published: (2021-06-01)

Histopathology of post kala-azar dermal leishmaniasis
by: V Ramesh, et al.
Published: (2020-01-01)

Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
by: Keerti Kaumudee Dixit, et al.
Published: (2020-01-01)

Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
by: Krishna Pandey, et al.
Published: (2020-12-01)

Kala-azar in a Brazilian child
by: Michael K. Hole, et al.
Published: (2011-04-01)

Kala-azar in Maraveh Tapeh county, Golestan Provice, Iran: Seven case reports
by: M Qorbani, et al.
Published: (2017-05-01)

Epidemiology of post-kala-azar dermal leishmaniasis
by: Pramit Ghosh, et al.
Published: (2021-01-01)

Kala-azar Control, Uganda
by: Jan H. Kolaczinski, et al.
Published: (2007-03-01)

Atypical post kala azar dermal leishmaniasis with ′′Muzzle area′′ swelling
by: Sandeep Arora, et al.
Published: (2015-01-01)

DNA-based detection of Leishmania and Crithidia species isolated from humans in cutaneous and post-kala-azar dermal leishmaniasis from Shiraz and Kharameh, southern Iran
by: Mohsen Kalantari, et al.
Published: (2020-01-01)

Kala-azar Epidemiology and Control, Southern Sudan
by: Jan H. Kolaczinski, et al.
Published: (2008-04-01)

Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14–16 May 2018
by: Eduard E. Zijlstra, et al.
Published: (2020-03-01)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
by: Dinesh Mondal, et al.
Published: (2019-10-01)

Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients
by: Md Anik Ashfaq Khan, et al.
Published: (2021-09-01)

Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil
by: Elizabeth F. Daher, et al.

Predicting death from kala-azar: construction, development, and validation of a score set and accompanying software
by: Dorcas Lamounier Costa, et al.

Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report
by: José Angelo Lauletta Lindoso, et al.

Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme
by: N A Siddiqui, et al.
Published: (2019-01-01)

Unusual Observations in Leishmaniasis—An Overview
by: Priya Yadav, et al.
Published: (2023-02-01)

Nutritional status and vitamin A and zinc levels in patients with kala-azar in Piauí, Brazil
by: Mísia Joyner de Sousa Dias Monteiro, et al.
Published: (2021-09-01)

Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features
by: Mehdi Mohebali
Published: (2013-09-01)

Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India
by: Arvind Kumar, et al.
Published: (2020-01-01)

Epidemiology of human visceral leishmaniasis in the urban centers of the lower-middle São Francisco Valley, Brazilian semiarid region
by: Lucyo Flávio Bezerra Diniz, et al.

Role of IL-17 gene polymorphism in Indian kala-azar
by: R Khatonier, et al.
Published: (2020-01-01)

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
by: Huda M, et al.
Published: (2012-11-01)

Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era
by: Rajesh Garlapati, et al.
Published: (2021-03-01)

The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS
by: Luis Gustavo Cavalcante Reinaldo, et al.
Published: (2024-03-01)

Low prevalence of <it>Leishmania donovani</it> infection among the blood donors in kala-azar endemic areas of Bangladesh
by: Huda M Mamun, et al.
Published: (2013-02-01)